T. Rowe Price Associates’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$361K	–	2957
2022 Q4	$361K	Sell	100,000 -12,576	-11%	-$82.3K	﹤0.01%	2299
2022 Q3	$997K	Sell	112,576 -15,418	-12%	-$128K	﹤0.01%	1753
2022 Q2	$986K	Sell	127,994 -31,601	-20%	-$253K	﹤0.01%	1901
2022 Q1	$1.51M	Hold	159,595	–	–	﹤0.01%	1809
2021 Q4	$1.11M	Hold	159,595	–	–	﹤0.01%	1983
2021 Q3	$1.52M	Hold	159,595	–	–	﹤0.01%	1847
2021 Q2	$1.59M	Buy	+159,595	New	+$1.78M	﹤0.01%	1842
2018 Q3	–	Sell	-84,401	Closed	-$3.62M	–	2614
2018 Q2	$3.62M	Sell	84,401 -72,177	-46%	-$3.31M	﹤0.01%	1477
2018 Q1	$10.2M	Sell	156,578 -21,226	-12%	-$1.5M	﹤0.01%	1328
2017 Q4	$13M	Buy	177,804 +35,068	+25%	+$2.9M	﹤0.01%	1293
2017 Q3	$13.1M	Buy	142,736 +76,847	+117%	+$5.89M	﹤0.01%	1292
2017 Q2	$4.36M	Buy	+65,889	New	+$8.16M	﹤0.01%	1429